Finance

Lists
PTIX:OTCMKTS
Protagenic Therapeutics Inc
$0.77
0.00%
(0.00) 1D
Oct 6, 3:42:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTIX...
Mkt. cap
1.39M
Avg. vol.
12.54K
Volume
46.00
P/E ratio
0.27
52-wk high
$3.77
52-wk low
$0.13
EPS
$2.83
Beta
1.75
Shares outstanding
1.81M
No. of employees
2
Mkt. cap
1.39M
Avg. vol.
12.54K
Volume
46.00
P/E ratio
0.27
52-wk high
$3.77
52-wk low
$0.13
EPS
$2.83
Beta
1.75
Shares outstanding
1.81M
No. of employees
2
News stories
From web sources and news partners
About Protagenic Therapeutics Inc
CEO-
Employees2
Founded1994
Headquarters-
SectorBiotechnology
Websiteprotagenic.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
273.23K
153.79K
157.94K
109.92K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
840.64K
771.32K
1.10M
784.31K
Operating expense
1.11M
925.10K
120.33K
961.25K
Total operating expenses
1.11M
925.10K
120.33K
961.25K
Operating income
-1.11M
-925.10K
-120.33K
-961.25K
Other non operating income
237.69K
3.14M
326.07K
-
EBT including unusual items
-869.50K
2.21M
5.08M
-963.62K
EBT excluding unusual items
-869.50K
2.21M
-1.11M
-950.28K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-869.50K
2.21M
5.08M
-963.62K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
10.76K
Interest expense
-
-
-1.31M
-
Net interest expenses
-
-
-1.31M
10.76K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.10M
-912.53K
-108.83K
-952.94K
Gain or loss from assets sale
-
-
-7.31M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps